Duchenne Muscular Dystrophy

• Bio News

  Sarepta Therapeutics Announces Expanded US FDA Approval of ELEVIDYS to Duchenne Muscular Dystrophy Patients Ages 4 and Above

  Congratulations to Sarepta Therapeutics and DMD patients!

  2024年6月21日

  3400